Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05364424
Title A Study Evaluating the Efficacy, Safety, and Pharmacokinetics of Glofitamab in Combination With Rituximab Plus Ifosfamide, Carboplatin Etoposide Phosphate in Participants With Relapsed/Refractory Transplant Eligible Diffuse B-Cell Lymphoma
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Hoffmann-La Roche
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Chao Family Comprehensive Cancer Center UCI Orange California 92868 United States Details
Memorial Cancer Institute at Memorial West Hollywood Florida 33021 United States Details
The University of Chicago Chicago Illinois 60637 United States Details
Tulane Medical Center; Investigational/Research Pharmacy New Orleans Louisiana 70112 United States Details
UMASS Memorial Medical Center Worcester Massachusetts 01655 United States Details
New York University Langone Medical Center New York New York 10016 United States Details
Cleveland Clinic Foundation; Cleveland Clinic Cancer Center/I40 Cleveland Ohio 44195 United States Details
MD Anderson Cancer Center Houston Texas 77030 United States Details
Medical College of Wisconsin Milwaukee Wisconsin 53226 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field